June 15, 2026 (HAMPTON, VA) — Teams from the United Network for Organ Sharing (UNOS), NASA Langley Research Center, and LifeNet Health successfully completed a groundbreaking study transporting human kidneys by drone beyond visual line of sight, marking a major milestone in the future of organ transportation and transplantation.

June 8, 2026 (Virginia Beach, VA) - LifeNet Health announced today that HCM Medical has transitioned into LifeNet Health Advanced Xeno‑Therapeutics (“LifeNet Health AXT”), marking a significant step in the organization’s strategy to advance regenerative medicine.

March 27, 2026 (Virginia Beach, VA) — LifeNet Health, a global leader in regenerative medicine, has received the Best Randomized Controlled Trial Award at the 2026 CAMPs Awards for its Matrion® diabetic foot ulcer study. In this randomized controlled trial of treatment-resistant diabetic foot ulcers, Matrion® delivered nearly double the likelihood of wound closure while demonstrating a substantially lower rate of serious adverse events compared with standard of care.

February 11, 2026 (Virginia Beach, VA) – LifeNet Health’s Organ Procurement Organization OPO continues to advance its mission to save and improve lives through organ donation. In 2025, LifeNet Health facilitated 266 donors who provided 774 organs for transplant, reflecting a 27.5% increase in organs transplanted since 2021, progress made possible through the generosity of donors and their families and the collaboration of hospital and transplant partners across Virginia and beyond.

February 4, 2026 (Virginia Beach, VA) – LifeNet Health announces that its Assay Services Laboratory in Kalamazoo, Michigan, has successfully completed an ISO 9001:2015 Quality Management System (QMS) certification, strengthening its ability to support pharmaceutical and biotechnology partners in developing safe, effective solutions that improve lives and expand access to healthcare.

December 15, 2025 – Virginia Beach, VA and Charleston, SC – LifeNet Health, a global leader in regenerative medicine, has acquired Tissue Testing Technologies LLC (T3), a biotechnology company specializing in biopreservation. T3 ‘s advanced proprietary technologies and services preserve living cells and tissues for clinical and research applications, ensuring the quality and impact of life-saving therapies.

Virginia Beach, VA, November 5, 2025 -- LifeNet Health proudly announces the recipients of its 2025 Partnership Excellence Awards, celebrating the extraordinary individuals and teams whose expertise and dedication transform tissue donations into lifesaving and life-enhancing gifts. These awards honor organ procurement organizations, tissue recovery operations, and recovery teams whose commitment ensures the utmost quality and that every donor is treated with dignity and respect.

September 16, 2025, 2025 (Virginia Beach, Va.) –The LifeNet Health Foundation invites you to join its Annual Race for Hope 5K/1 Mile Run on Saturday, October 11 at LifeNet Health’s Global Headquarters in Virginia Beach.

More than just a race, this powerful community event brings together donor families, healthcare heroes, and supporters from across Hampton Roads and beyond, all united by a shared mission: to save lives, restore health, and give hope.

August 20, 2025, Virginia Beach, VA & Nijmegen, Netherlands - In a transformative move to accelerate global access to life-restoring technologies, LifeNet Health, a world leader in regenerative medicine, has acquired HCM Medical, a Netherlands-based contract manufacturing organization (CMO) known for its pioneering biologics and tissue-processing capabilities.